Skip to main content
رجوع
Watch Compare

Journey Medical Corp

جودة البيانات: 100%
DERM
Nasdaq Manufacturing Chemicals
KWD 5.24
▼ KWD 0.09 (-1.69%)
القيمة السوقية: 174.26 M
السعر
KWD 5.24
القيمة السوقية
174.26 M
نطاق اليوم
KWD 5.00 — KWD 5.38
نطاق 52 أسبوعًا
KWD 4.31 — KWD 9.56
حجم التداول
101,804
فتح KWD 5.33
متوسط 50 يوم / 200 يوم
KWD 7.55
30.56% below
متوسط 50 يوم / 200 يوم
KWD 7.54
30.53% below

Quick Summary

النقاط الرئيسية

Revenue declined -0.51% annually over 5 years
Negative free cash flow of -12.44 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10.71%

النمو

Revenue Growth (5Y)
-0.51%
أقل من متوسط القطاع (9.35%)
Revenue (1Y)10.20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-50.64%
أعلى من متوسط القطاع (-51.02%)
ROIC-14.99%
Net Margin-18.48%
Op. Margin-13.21%

الأمان

Debt / Equity
0.97
أعلى من متوسط القطاع (0.33)
Current Ratio1.42
Interest Coverage-2.21

التقييم

PE (TTM)
-15.24
أقل من متوسط القطاع (-1.98)
P/B Ratio6.73
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -15.2 -2.0
P/B 6.7 5.1
ROE % -50.6 -51.0
Net Margin % -18.5 -150.2
Rev Growth 5Y % -0.5 9.3
D/E 1.0 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 10.20% Revenue Growth (3Y) -11.61%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -0.51% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 61.86 M Net Income (TTM) -11.43 M
ROE -50.64% ROA -13.74%
Gross Margin N/A Operating Margin -13.21%
Net Margin -18.48% Free Cash Flow (TTM) -12.44 M
ROIC -14.99% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.97 Current Ratio 1.42
Interest Coverage -2.21 Asset Turnover 0.74
Working Capital 16.67 M Tangible Book Value -2.77 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -15.24 Forward P/E N/A
P/B Ratio 6.73 P/S Ratio 2.82
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7.14%
Market Cap 174.26 M Enterprise Value 174.48 M
Per Share
EPS (Diluted TTM) -0.47 Revenue / Share 1.86
FCF / Share -0.37 OCF / Share -0.37
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 108.84%
SBC-Adj. FCF -18.59 M Growth Momentum 10.71

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 61.86 M 56.13 M 79.18 M 73.67 M 63.13 M
Net Income -11.43 M -14.67 M -3.85 M -29.63 M -43.99 M
EPS (Diluted) -0.47 -0.72 -0.21 -1.69 -4.32
Gross Profit — — — — —
Operating Income -8.17 M -13.68 M -2.07 M -27.52 M -34.88 M
EBITDA — — — — —
R&D Expenses 480,000.0 9.86 M 7.54 M 10.94 M 2.74 M
SG&A Expenses 44.37 M 40.20 M 43.91 M 59.47 M 39.83 M
D&A — — — — 0.0
Interest Expense 3.70 M 2.70 M 1.70 M 2.02 M 7.03 M
Income Tax 60,000.0 61,000.0 221,000.0 63,000.0 1.63 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 94.59 M 80.24 M 76.85 M 105.16 M 97.28 M
Total Liabilities 62.74 M 60.17 M 56.50 M 88.18 M 55.24 M
Shareholders' Equity 31.85 M 20.07 M 20.35 M 16.98 M 42.04 M
Total Debt 25.28 M 24.88 M 14.62 M 27.77 M —
Cash & Equivalents 24.09 M 20.31 M 27.44 M 32.00 M 49.08 M
Current Assets 66.87 M 48.18 M 56.46 M 77.68 M 84.49 M
Current Liabilities 37.44 M 35.18 M 41.87 M 66.83 M 51.61 M